Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

		Keywords:		Sunitinib

		Phase:		Phase 2

		Treatment ID#s:		VT1887 NCT00589784

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: Y Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		10/09/2008

		Tumor Types:		Meningioma


		Comments:

		Treatment Type:		Less-Toxics.

		Contact:		Memorial Sloan-Kettering Cancer Center Lauren Abrey, MD Dept. Of Neurology 1275 York Ave New York, NY 10021 Phone:(212)639-5122 Fax: (212)717-3551 Click here to send an email U. of Pittsburgh Medical Center Frank Lieberman, MD Contact: Melissa Clark 5115 Centre Avenue Pittsburgh, PA 15232 Phone:412-647-9578 Click here to send an email Website: www.upmccancercenters.com/brain/treated.cfm University of Virginia Health System David Schiff, MD Co-Director, Division of Neuro-Oncology Department of Neurology Box 800432 Charlottesville, VA 22908-0432 Phone:434-982-4415 Fax: 434-982-4467 Click here to send an email Website: www.uvabraintumor.com

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By